Rituximab therapy is more effective than cyclophosphamide therapy for Japanese patients with anti‐topoisomerase I‐positive systemic sclerosis‐associated interstitial lung disease

Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study

(2019) Muriel Elhai et al.   ANNALS OF THE RHEUMATIC DISEASES

Pathogenic roles of B lymphocytes in systemic sclerosis

(2018) Ayumi Yoshizaki   IMMUNOLOGY LETTERS

High acute phase protein levels correlate with pulmonary and skin involvement in patients with diffuse systemic sclerosis

(2018) Anna Lis-Święty et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

Rituximab Experience in Patients With Long-standing Systemic Sclerosis–Associated Interstitial Lung Disease

(2017) Alper Sari et al.   JCR-JOURNAL OF CLINICAL RHEUMATOLOGY

A multicenter, open-label, comparative study of B-cell depletion therapy with Rituximab for systemic sclerosis-associated interstitial lung disease

(2017) Dimitrios Daoussis et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Update of EULAR recommendations for the treatment of systemic sclerosis

(2016) Otylia Kowal-Bielecka et al.   ANNALS OF THE RHEUMATIC DISEASES

The first case report of fatal acute pulmonary dysfunction in a systemic sclerosis patient treated with rituximab

(2016) K Nakamura et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

Abnormal B Lymphocyte Activation and Function in Systemic Sclerosis

(2015) Ayumi Yoshizaki et al.   Annals of Dermatology

Association of HLA-DRB1 Haplotypes With Rheumatoid Arthritis Severity, Mortality, and Treatment Response

(2015) Sebastien Viatte et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Management of Systemic-Sclerosis-Associated Interstitial Lung Disease

(2015) Katherine Culp Silver et al.   RHEUMATIC DISEASE CLINICS OF NORTH AMERICA

Rituximab in diffuse cutaneous systemic sclerosis: should we be using it today?

(2015) F. M. McQueen et al.   RHEUMATOLOGY

Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group

(2014) Suzana Jordan et al.   ANNALS OF THE RHEUMATIC DISEASES

Interstitial lung disease in connective tissue disease—mechanisms and management

(2014) Athol U. Wells et al.   Nature Reviews Rheumatology

Complete Haplotype Sequence of the Human Immunoglobulin Heavy-Chain Variable, Diversity, and Joining Genes and Characterization of Allelic and Copy-Number Variation

(2013) Corey T. Watson et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Basis of Acute Exacerbation of Idiopathic Pulmonary Fibrosis in Japanese Patients

(2013) Arata Azuma et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative

(2013) Frank van den Hoogen et al.   ANNALS OF THE RHEUMATIC DISEASES

Treating CTDs Related Fibrotic ILDs by Immunosuppressants: “Facts and Faults”

(2013) Spyros A. Papiris et al.   LUNG

Does C-Reactive Protein Predict the Long-Term Progression of Interstitial Lung Disease and Survival in Patients With Early Systemic Sclerosis?

(2013) Xiaochun Liu et al.   ARTHRITIS CARE & RESEARCH

Anti-topoisomerase I antibody levels as serum markers of skin sclerosis in systemic sclerosis

(2012) Minoru Hasegawa et al.   JOURNAL OF DERMATOLOGY

Two-year Results of an Open Pilot Study of a 2-treatment Course with Rituximab in Patients with Early Systemic Sclerosis with Diffuse Skin Involvement

(2012) V. SMITH et al.   JOURNAL OF RHEUMATOLOGY

Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions

(2012) Ayumi Yoshizaki et al.   NATURE

Treatment of Systemic Sclerosis Complications: What to Use When First-Line Treatment Fails—A Consensus of Systemic Sclerosis Experts

(2012) Kyle M. Walker et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Association of C-reactive protein with high disease activity in systemic sclerosis: Results from the Canadian Scleroderma Research Group

(2012) Chayawee Muangchan et al.   ARTHRITIS CARE & RESEARCH

Forced Vital Capacity in Patients with Idiopathic Pulmonary Fibrosis

(2011) Roland M. du Bois et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

B cells in systemic sclerosis: A possible target for therapy

(2011) Silvia Bosello et al.   AUTOIMMUNITY REVIEWS

Non-infectious pulmonary toxicity of rituximab: a systematic review

(2011) A. V. Hadjinicolaou et al.   RHEUMATOLOGY

B cell depletion in diffuse progressive systemic sclerosis: safety, skin score modification and IL-6 modulation in an up to thirty-six months follow-up open-label trial

(2010) Silvia Bosello et al.   ARTHRITIS RESEARCH & THERAPY

EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR)

(2009) O Kowal-Bielecka et al.   ANNALS OF THE RHEUMATIC DISEASES

B cell depletion with rituximab in patients with diffuse cutaneous systemic sclerosis

(2009) Robert Lafyatis et al.   ARTHRITIS AND RHEUMATISM

Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study

(2009) Dimitrios Daoussis et al.   RHEUMATOLOGY

Interstitial Lung Disease in Japanese Patients with Lung Cancer

(2008) Shoji Kudoh et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Rituximab in diffuse cutaneous systemic sclerosis: an open-label clinical and histopathological study

(2008) V Smith et al.   ANNALS OF THE RHEUMATIC DISEASES

A pilot study of subclinical coronary atherosclerosis in systemic sclerosis: Coronary artery calcification in cases and controls

(2008) Vandana Khurma et al.   ARTHRITIS AND RHEUMATISM